Max Healthcare Institute Limited (NSE:MAXHEALTH)
India flag India · Delayed Price · Currency is INR
1,023.05
-68.05 (-6.24%)
May 22, 2026, 3:30 PM IST

Max Healthcare Institute Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
83,73570,28554,06045,62639,366
83,73570,28554,06045,62639,366
Revenue Growth (YoY)
19.14%30.01%18.49%15.90%56.96%
Cost of Revenue
31,47126,51120,52917,31417,481
Gross Profit
52,26343,77433,53128,31221,885
Selling, General & Admin
17,94014,74711,1699,8638,729
Other Operating Expenses
11,89510,1577,1595,8873,365
Operating Expenses
34,30028,49920,77818,07214,305
Operating Income
17,96315,27512,75310,2407,580
Interest Expense
-2,351-1,488-445.6-713.2-900.1
Interest & Investment Income
1,1501,1721,5621,124750.9
Currency Exchange Gain (Loss)
--73-2.4-3.4
Other Non Operating Income (Expenses)
475.8204.441.686.7207.3
EBT Excluding Unusual Items
17,23815,15813,91410,7357,634
Merger & Restructuring Charges
-----90.3
Gain (Loss) on Sale of Assets
-1.14.513.3-30.6
Asset Writedown
-----0.6
Other Unusual Items
-482.4-1,095-265.4-111.2-123.8
Pretax Income
16,75614,06413,65310,6377,389
Income Tax Expense
2,3323,3053,077-397.91,339
Earnings From Continuing Operations
14,42410,75910,57611,0356,051
Net Income to Company
14,42410,75910,57611,0356,051
Net Income
14,42410,75910,57611,0356,051
Net Income to Common
14,42410,75910,57611,0356,051
Net Income Growth
34.07%1.73%-4.16%82.38%-
Shares Outstanding (Basic)
973972972970967
Shares Outstanding (Diluted)
977977975972969
Shares Change (YoY)
-0.02%0.20%0.39%0.24%12.30%
EPS (Basic)
14.8311.0710.8911.386.25
EPS (Diluted)
14.7611.0110.8411.366.24
EPS Growth
34.06%1.57%-4.58%82.05%-
Free Cash Flow
1,4884,9383,3579,4851,872
Free Cash Flow Per Share
1.525.053.449.761.93
Dividend Per Share
2.0001.5001.5001.000-
Dividend Growth
33.33%-50.00%--
Gross Margin
62.41%62.28%62.02%62.05%55.59%
Operating Margin
21.45%21.73%23.59%22.44%19.25%
Profit Margin
17.23%15.31%19.56%24.19%15.37%
Free Cash Flow Margin
1.78%7.03%6.21%20.79%4.75%
EBITDA
22,42818,31214,81912,2269,465
EBITDA Margin
26.78%26.05%27.41%26.80%24.04%
D&A For EBITDA
4,4653,0372,0661,9861,886
EBIT
17,96315,27512,75310,2407,580
EBIT Margin
21.45%21.73%23.59%22.44%19.25%
Effective Tax Rate
13.92%23.50%22.54%-18.12%
Revenue as Reported
85,36171,84155,83047,01840,588
Advertising Expenses
----446.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.